Treace Medical Concepts, Inc. TMCI
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -21.01% | -15.20% | -5.85% | 18.55% | 22.77% |
| Total Depreciation and Amortization | -12.55% | 1.13% | 29.71% | 21.49% | 22.94% |
| Total Amortization of Deferred Charges | 27.14% | 14.11% | -0.46% | 62.86% | 62.53% |
| Total Other Non-Cash Items | -1.36% | 7.70% | 15.33% | 30.24% | 31.92% |
| Change in Net Operating Assets | 86.03% | 91.93% | 66.25% | -25.65% | -337.83% |
| Cash from Operations | 2.18% | 49.79% | 57.03% | 62.53% | 50.49% |
| Capital Expenditure | 26.51% | -16.30% | -16.60% | -31.82% | -24.92% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 53.85% | -50.25% | -43.01% | -55.58% | -61.27% |
| Cash from Investing | 337.74% | -75.34% | -62.54% | -81.04% | -88.73% |
| Total Debt Issued | 6,091.56% | -- | -- | -- | -- |
| Total Debt Repaid | -58,948.98% | -- | -- | -- | -- |
| Issuance of Common Stock | 36.67% | 4.65% | 27.57% | -2.91% | -96.34% |
| Repurchase of Common Stock | -61.43% | -63.89% | -236.57% | -243.20% | -78.40% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 100.27% | 2,711.11% | 1,198.13% | 141.14% | 64.22% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 145.00% | -194.80% | 60.66% | -191.56% | -264.81% |